The Ethics of Ghost Authorship in Biomedical Research:
Concerns and Remedies
Workshop
Wednesday May 4th, 2011 from 8:30 am to 5:15 pm

FLA (Classroom A), Flavelle House, 78 Queen’s Park Avenue,
Faculty of Law, University of Toronto

Bibliography

 

General Background Reading

  1. Washington University in St. Louis, Washington University Research Integrity Policy

  2. Industry Funding of Medical Education: Report of an AAMC Task Force (2008) Association of American Medical Colleges.

  3. Catherine D. DeAngelis; Phil B. Fontanarosa. Impugning the Integrity of Medical Science: The Adverse Effects of Industry Influence. JAMA. 2008;299(15):1833-1835 (doi:10.1001/jama.299.15.1833)

  4. Ford AR, Saibil D. The Push to Prescribe: Women & Canadian Drug Policy.
    http://www.nnewh.org/article.php?itemID=49&section=1

  5. Lemmens T (2004) Leopards in the temple: restoring scientific integrity to the commercialized research scene. J Law Med Ethics 32: 641-657.

  6. Lemmens T (2004) Piercing the veil of corporate secrecy about clinical trials. Hastings Cent Rep 34: 14-18.

  7. Bouchard RA, Lemmens T (2008) Privatizing biomedical research--a “third way.” Nat. Biotechnol 26: 31-36. doi:10.1038/nbt0108-31

On Ghost Authorship

  1. Mario Biagioli, “Documents of Documents: Scientists' Names and Scientific Claims”, in Annelise Riles (ed), Documents: Artifacts of Modern Knowledge, (Ann Arbor: University of Michigan Press, 2006), pp. 129-156.

  2. Healy D., (2008), Our Censored Journals. In: Medicine, Mental Health, Science, Religion, and Well-being (A.R. Singh and S.A. Singh eds.), MSM, 6, Jan-Dec 2008, p244-256

  3. McHenry L., (2010), Of Sophists and Spin-Doctors: Industry-Sponsored Ghostwriting and the Crisis of Academic Medicine. In: Psychopharmacology Today: Some Issues (A.R. Singh and S.A. Singh eds.), MSM, 8, Jan - Dec 2010, p129-145.
    http://www.msmonographs.org/article.asp?issn=0973-1229;year=2010;volume=8;issue=1;spage=129;epage=145;aulast=McHenry

  4. Healy D, Cattell D (2003) Interface between authorship, industry and science in the domain of therapeutics. Br J Psychiatry 183: 22-27.

  5. Matheson, AD. Corporate science and the husbandry of scientific and medical knowledge by the pharmaceutical industry.
    BioSocieties 2008; 3: 355-382

  6. McHenry L B, Jureidini JN (2008) Industry-sponsored ghostwriting in clinical trial reporting: a case study. Account Res 15: 152-167. http://www.informaworld.com/smpp/content~db=all~content=a794712276~frm=abslink

  7. McHenry L (2005) On the origin of great ideas: science in the age of big pharma. Hastings Cent Rep 35: 17-19. http://muse.jhu.edu/journals/hastings_center_report/toc/hcr35.6.html

  8. United States Senate Committee on Finance (2010) Ghostwriting in Medical LiteratureMinority Staff Report, 111th Congress, Sen. Charles E. Grassley, Ranking Member. p.

  9. Sismondo S, Doucet M (2010) Publication ethics and the ghost management of medical publication. Bioethics 24: 273-283. doi:10.1111/j.1467-8519.2008.01702.x

  11. Fugh-Berman AJ (2010) The Haunting of Medical Journals: How Ghostwriting Sold “HRT”. PLoS Med 7(9): e1000335. doi:10.1371/journal.pmed.1000335

  12. Lacasse JR, Leo J (2010) Ghostwriting at Elite Academic Medical Centers in the United States. PLoS Med 7(2): e1000230. doi:10.1371/journal.pmed.1000230

  13. The PLoS Medicine Editors (2009) Ghostwriting: The Dirty Little Secret of Medical Publishing That Just Got Bigger. PLoS Med 6(9): e1000156. doi:10.1371/journal.pmed.1000156

  14. Gøtzsche PC, Kassirer JP, Woolley KL, Wager E, Jacobs A, et al. (2009) The PLoS Medicine Debate: What Should Be Done To Tackle Ghostwriting in the Medical Literature? PLoS Med 6(2): e1000023. doi:10.1371/journal.pmed.1000023

  15. Sismondo S (2007) Ghost Management: How Much of the Medical Literature Is Shaped Behind the Scenes by the Pharmaceutical Industry? PLoS Med 4(9): e286. doi:10.1371/journal.pmed.0040286

  16. Gøtzsche PC, Hróbjartsson A, Johansen HK, Haahr MT, Altman DG, et al. (2007) Ghost Authorship in Industry-Initiated Randomised Trials. PLoS Med 4(1): e19. doi:10.1371/journal.pmed.0040019

  17. Lundh A, Barbateskovic M, Hróbjartsson A, Gøtzsche PC (2010) Conflicts of Interest at Medical Journals: The Influence of Industry-Supported Randomised Trials on Journal Impact Factors and Revenue – Cohort Study. PLoS Med 7(10): e1000354. doi:10.1371/journal.pmed.1000354